This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Intrasaccular Embolization Systems Market

Market Insights on Intrasaccular Embolization Systems covering sales outlook, demand forecast & up-to-date key trends

Intrasaccular Embolization Systems Market By Product Type (Embolic Coils, Woven Endobridge (WEB), Medina Embolization Device), End User (Hospitals, Specialty Clinics, Ambulatory Surgery Centre) & Region - Forecast 2022-2032

Intrasaccular Embolization Systems Market Overview

Global intrassacular embolization systems market demand is anticipated to be valued at US$ 2,920.44 Million in 2022, forecast to grow at a CAGR of 7.2% to be valued at US$ 5,861.41 Million from 2022 to 2032. The demand is expected to soar up in East Asia owing to the recent surge in healthcare standards in emerging countries like Japan and China.

Report Attribute


Estimated Base Year Value (2021)

US$ 2,715 Million

Expected Market Value (2022)

US$ 2,920.44 Million

Anticipated Forecast Value (2032)

US$ 5,861.41 Million

Projected Growth Rate (2022-2032)

7.2% CAGR

An aneurysm occurs when a section of an artery wall weakens, allowing it to balloon out or widen abnormally. A stroke, blood clots, and increased intracranial pressure can all result from a bleed. Intrasaccular Embolization Systems typically involve restricting blood flow in an aneurysm that has formed.

Intrassacular Embolization Systems are surgical interventions that are used to fill aneurysms. Typically, an embolic coil is inserted into the aneurysms and blood platelets in the brain are restricted. The Intrasaccular Embolization Systems promote rapid clotting and the prevention of further brain damage. The use of preventive stenting by Intrasaccular Embolization Systems reduces the risk of surgical intervention in adjacent parts of the brain.

Furthermore, endovascular repair is used to achieve hemostasis. The time required to receive the Intrasaccular Embolization procedure is critical to the survival of patients with intracranial aneurysms. The Intrasaccular Embolization System provides a significant advantage in terms of patient recovery.

Which are Some Prominent Drivers Spearheading Intrasaccular Embolization Systems Market Growth?

The rising incidence of brain aneurysms is a major driving factor for the Intrasaccular Embolization Systems market, owing to the rising burden of chronic diseases. Aneurysms account for approximately 10-12% of stroke cases, according to the American Brain Aneurysm Foundation. Whereas approximately 10% to 14% of people suffer from intracranial bleeding, which results in death.

The market for Intrasaccular Embolization Systems is being driven by an increase in new cases of venous diseases. Furthermore, the increased use of antihypertensive drugs raises the risk of intracranial aneurysms, increasing the demand for Intrasaccular Embolization Systems. The main advantage of a device-based Intrasaccular Embolization System is its quick action and reduced recovery time, which in the case of intracranial aneurysms results in the patient's well-being. The shorter onset of action of a coil or WEB system is expected to boost the market for Intrasaccular Embolization Systems.

The increasing prescription rate of antihypertensive drugs by physicians and the high clinical effectiveness of Intrasaccular Embolization Systems are expected to expand the market for Intrasaccular Embolization System. The increased use of venous dilators, combined with an increase in the number of patients with high blood pressure, is expected to increase the risk of aneurysms and stroke, propelling the market for Intrasaccular Embolization Systems.

Customize this Report

Let us know your requirement to get
100% FREE customization

What are the Challenges Faced by the Intrasaccular Embolization Systems Market Industry?

Rigid regulatory guidelines for devices used in Intrasaccular Embolization Systems, combined with the high cost of the procedure, are expected to limit the global Intrasaccular Embolization Systems Market's growth.

Why is North America emerging as an Opportunistic Intrasaccular Embolization Systems Market?

Because of higher technological advancement and recent FDA approvals for WEB systems, North America is expected to be the dominant market in the global intrasaccular embolization systems market during the forecast period.

Sabyasachi Ghosh
Principal Consultant
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

How is Europe Contributing to Growth of the Intrasaccular Embolization Systems Market?

According to Future Market Insights, Europe is expected to provide immense growth opportunities for Intrasaccular Embolization Systems Market. Extensive applications in the health industry are keeping sales of Intrasaccular Embolization Systems Market afloat across the region.

Europe is generating high demand for Intrasaccular Embolization Systems Market, as these regions are witnessing an uptick in construction activity. Moreover, the chemical industry in these countries is also experiencing a major upsurge, which will generate favorable conditions for market growth.

Market Competition

The global market for Intrasaccular Embolization Systems is fragmented with large number of market players. Examples of some of the primary key players operating in the global Intrasaccular Embolization Systems market are MicroVention, Inc., Medtronic Plc., Stryker Corporation, Cook Medical, dePuySynthes, Kaneka Pharmaceuticals, Penubbra and Braile Biomedica among others.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Report Scope

Report Attribute


Growth Rate

CAGR of 5.2% from 2022 to 2032

Base Year for Estimation


Historical Data


Forecast Period


Quantitative Units

Revenue in USD Billion, Volume in Kilotons and CAGR from 2022-2032

Report Coverage

Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis

Segments Covered

  • Product Type
  • End User
  • Region

Regions Covered

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East & Africa

Key Countries Profiled

  • U.S
  • Canada
  • Brazil
  • Argentina
  • Chile
  • Peru
  • Germany
  • U.K
  • France
  • Spain
  • Italy
  • Nordics
  • Australia & New Zealand
  • China
  • India
  • GCC
  • South Africa
  • Turkey
  • Iran
  • Israel

Key Companies Profiled

  • MicroVention, Inc.
  • Medtronic Plc.
  • Stryker Corporation
  • Cook Medical
  • dePuySynthes
  • Kaneka Pharmaceuticals
  • Penubbra
  • Braile Biomedica


Available Upon Request

Key Segments Profiled in the Intrasaccular Embolization Systems Market Industry Survey

Product Type:

  • Intrasaccular Embolic Coils
  • Intrasaccular Woven Endobridge (WEB)
  • Medina Intrasaccular Embolization Device
  • Other Intrasaccular Embolization Product Types

End User:

  • Intrasaccular Embolization for Hospitals
  • Intrasaccular Embolization for Specialty Clinics
  • Intrasaccular Embolization for Ambulatory Surgery Centres
  • Intrasaccular Embolization for Other End Users


  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East & Africa

Frequently Asked Questions

FMI projects the global Intrasaccular Embolization Systems Market to expand at a 7.2% value CAGR by 2032

North America is expected to be the most opportunistic Intrasaccular Embolization Systems Market.

MicroVention, Inc., Medtronic Plc. and stryker are some prominent Intrasaccular Embolization Systems Market manufacturers

Table of Content


Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables


Sabyasachi Ghosh
Principal Consultant
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts


Need specific information?

Request Customization

Explore Healthcare Insights

View Reports



Sleep Apnea Diagnostic Systems Market

Published : August 2021


Continuous Glucose Monitoring Systems Market

Published : July 2015


Electrophysiology Equipment and Recording Systems Market

Published : January 1970

Google translate

Intrasaccular Embolization Systems Market